Judge Cites Cert Grant In Keeping Lexapro Cases Alive

Law360, New York (July 25, 2008, 12:00 AM EDT) -- A federal judge on Thursday denied Forest Laboratories Inc.'s motion to dismiss 22 actions in the Celexa and Lexapro multidistrict litigation because of the U.S. Supreme Court's decision to grant certiorari in Levine v. Wyeth, which also deals with the question of federal preemption in product liability suits.

On July 18, Forest asked the U.S. District Court for the Eastern District of Missouri to dismiss close to half of the claims against the company in the suit because of conflict preemption.

That motion dealt only with...
To view the full article, register now.




Case Information

Case Title

In Re: Celexa and Lexapro Products Liability Litigation

Case Number



Missouri Eastern

Nature of Suit

Personal Inj. Prod. Liability


Rodney W. Sippel

Date Filed

February 17, 2006

Law Firms


Government Agencies

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.